Ovarian cancer trials in Finland

In Finland 10 Also abroad 795

10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Where
Kuopio, Oulu, Tampere
Age
18 years and over
People
770 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06824467 · EU 2023-508015-23-00
Phase 3Taking people
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Where
Kuopio, Oulu, Tampere, Turku
Age
18 years and over
People
900 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07318558 · EU 2023-508047-40-00
Phase 3Taking people
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Where
Kuopio, Oulu, Tampere
Age
18 years and over
People
420 worldwide
Run by
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
See details and how to joinNCT07546500
Phase 3Taking people
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
Where
Kuopio, Tampere, Turku
Age
18 years and over
People
688 worldwide
Run by
Genmab
See details and how to joinNCT07564141 · EU 2025-524202-15-00
Phase 2/3Taking people
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Where
Kuopio
Age
18 years and over
People
860 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06161025 · EU 2023-507914-28-00
Phase 3Taking people
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Where
Kuopio, Oulu, Tampere, Turku
Age
18 years and over
People
544 worldwide
Run by
Genmab
See details and how to joinNCT07225270 · EU 2025-522167-15-00
Phase 3Taking people
Measuring Oncological Value of Exercise and Statin (MOVES)
Where
Tampere
Age
18 years and over
People
240
Run by
Pirkanmaan hyvinvointialue
See details and how to join2024-515109-24-00 · EU 2024-515109-24-00
Phase 3Taking people
Measuring Oncological Value of Exercise and Statin
Where
Tampere
Age
18 years to 99 years
People
240
Run by
Tampere University Hospital
See details and how to joinNCT05796973
No phaseTaking people
Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC
Where
Turku
Age
18 years and over
People
200
Run by
Turku University Hospital
See details and how to joinNCT04846933
No phaseTaking people
Systems Oncology Approach to Optimize Ovarian Cancer Treatment
Where
Helsinki
People
500
Run by
University of Helsinki
See details and how to joinNCT06117384